Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Business models
Business models
B2B
Products 71 to 80 of 162
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Fueltase™ phytase
by
BASF
Biotech components:
Enzyme
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/05/15 15:45 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
Open Release
Source:
Web search
Trading symbol:
BAS
(ETR)
Value chain stage:
Input
Fuelzyme 650 Alpha-amylase
by
BASF
+
Verenium
Biotech components:
Enzyme
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
USA
+
Europe
+
Asia
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/05/15 15:45 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BAS
(ETR)
Value chain stage:
Input
Fumaric Acid
by
GC Innovation America
+
Myriant
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/09/13 15:29 (6 years ago)
Known funding amount:
110,000,000 USD
Funding types:
Government
+
Venture Capital
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Gen 3 technical and medical fiber
by
Kraig Biocraft Laboratories
Biotech components:
Animal
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
1,200,000 USD
Funding types:
Shareholder Investment
+
Government
Industry:
Medical
+
Industrial
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Fiber
Production process:
Closed Production
Source:
Web search
Trading symbol:
KBLB
(OTCQB)
Value chain stage:
Input
Genetic Circuits
by
MIT
Biotech components:
Virus
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Research
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
Industry:
Health
Market status:
Under Development
Organization type(s):
University
+
Research Institution
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Genetic Security System
by
Wyss Institute
+
Harvard University
Biotech components:
Bacteria
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
3,700,000 USD
Funding types:
Government
Industry:
Security
Market status:
Early Stage Concept
Organization type(s):
Research Institution
Product categories:
Forensic Tagging
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Input
GM Tomato Resistance (Ptr 1 gene) to Bacterial Speck Disease
by
Boyce Thompson Institute
Biotech components:
Gene Editing
+
Plant
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:38 (4 years ago)
Date last modified:
2020/12/18 14:38 (4 years ago)
Known funding amount:
N/A
Funding types:
Research Institution
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Research Institution
Product categories:
Food
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
GM Yeast to make Cannabis
by
University of California, Berkeley
+
Demetrix Inc.
Biotech components:
Yeast
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:18 (5 years ago)
Date last modified:
2019/09/12 15:18 (5 years ago)
Known funding amount:
11,000,000 USD
Funding types:
Venture Capital
Industry:
Medical
Market status:
Early Stage Concept
Organization type(s):
Private Company
+
University
Product categories:
Medicine
Production process:
N/A
Source:
Scientist Magazine
Trading symbol:
N/A
Value chain stage:
Input
GMO Low-Fat Pigs
by
Institute of Zoology at the Chinese Academy of Sciences
Biotech components:
Animal
Business models:
B2B
Country of production:
China
Country of distribution:
China
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/08 14:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Government
Industry:
Food & Agriculture
Market status:
Early Stage Concept
Organization type(s):
Research Institution
+
University
Product categories:
Animal
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Hexamethylenediamine
by
Rennovia
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
78,500,000 USD
Funding types:
Venture Capital
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
1
…
3
4
5
6
7
8
9
10
11
12
…
17
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About